Identification of a New Series of STAT3 Inhibitors by Virtual Screening-Reference-Cited by-同舟云学术

Identification of a New Series of STAT3 Inhibitors by Virtual Screening

Published:2010-07-13 Issue:8 Volume:1 Page:371-375
ISSN:1948-5875
Container-title:ACS Medicinal Chemistry Letters
language:en
Short-container-title:ACS Med. Chem. Lett.

Author:

Matsuno Kenji¹,Masuda Yoshiaki¹²,Uehara Yutaka¹,Sato Hiroshi¹,Muroya Ayumu²,Takahashi Osamu²,Yokotagawa Takane²,Furuya Toshio²,Okawara Tadashi³,Otsuka Masami⁴,Ogo Naohisa⁵,Ashizawa Tadashi⁶,Oshita Chie⁶,Tai Sachiko⁶,Ishii Hidee⁶,Akiyama Yasuto⁶,Asai Akira¹

Affiliation:

1. Center for Drug Discovery, Graduate School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka, 422-8526, Japan

2. PharmaDesign, Inc., 2-19-8 Hatchobori, Chuo-ku, Tokyo, 104-0032, Japan

3. Kumamoto Health Science University, 325 Izumimachi, Kumamoto, 861-5598, Japan

4. Faculty of Medical and Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Kumamoto, 862-0973, Japan

5. Shizuoka Institute of Environment and Hygiene, 4-27-2 Kita-ando, Aoi-ku, Shizuoka, 420-8637, Japan

6. Shizuoka Cancer Center Research Institute, 1007 Shimo-nagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka, 411-8777, Japan

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Drug Discovery,Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/ml1000273

Reference23 articles.

1. STATs: transcriptional control and biological impact

2. The STATs of cancer — new molecular targets come of age

3. Validating Stat3 in cancer therapy

4. STAT proteins as novel targets for cancer drug discovery

5. Mechanisms of Disease: insights into the emerging role of signal transducers and activators of transcription in cancer

Cited by 131 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluating the specific STAT3 inhibitor YHO-1701 in ovarian cancer cell lines and patient-derived cell models: efficacy, mechanisms, and therapeutic potential;Journal of Gynecologic Oncology;2025

2. In-silico assessment of novel peptidomimetics inhibitor targeting STAT3 and STAT4 N-terminal domain dimerization: A comprehensive study using molecular docking, molecular dynamics simulation, and binding free energy analysis;Biochemical and Biophysical Research Communications;2024-11

3. Selective STAT3 inhibitor STX-0119 alleviates osteoarthritis progression by modulating the STAT3/PPARγ signaling pathway;Biochemical Pharmacology;2024-09

4. Network pharmacology and experimental insights into STAT3 inhibition by novel isoxazole derivatives of piperic acid in triple negative breast cancer;Fitoterapia;2024-06

5. Synthesis and biological studies of pyrimidine derivatives targeting metabolic enzymes;Archiv der Pharmazie;2024-05-21